Soleno Therapeutics (SLNO) Competitors $57.78 +3.15 (+5.77%) (As of 11/22/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends SLNO vs. RYTM, FONR, EDAP, RMTI, PEN, GKOS, BLCO, INSP, PRCT, and NVSTShould you be buying Soleno Therapeutics stock or one of its competitors? The main competitors of Soleno Therapeutics include Rhythm Pharmaceuticals (RYTM), FONAR (FONR), Edap Tms (EDAP), Rockwell Medical (RMTI), Penumbra (PEN), Glaukos (GKOS), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), PROCEPT BioRobotics (PRCT), and Envista (NVST). These companies are all part of the "medical" sector. Soleno Therapeutics vs. Rhythm Pharmaceuticals FONAR Edap Tms Rockwell Medical Penumbra Glaukos Bausch + Lomb Inspire Medical Systems PROCEPT BioRobotics Envista Rhythm Pharmaceuticals (NASDAQ:RYTM) and Soleno Therapeutics (NASDAQ:SLNO) are both mid-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, earnings, analyst recommendations, community ranking, media sentiment, institutional ownership, dividends, valuation and risk. Which has higher valuation & earnings, RYTM or SLNO? Soleno Therapeutics has lower revenue, but higher earnings than Rhythm Pharmaceuticals. Soleno Therapeutics is trading at a lower price-to-earnings ratio than Rhythm Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRhythm Pharmaceuticals$112.53M32.74-$184.68M-$4.33-13.84Soleno TherapeuticsN/AN/A-$38.99M-$3.32-17.40 Does the MarketBeat Community prefer RYTM or SLNO? Soleno Therapeutics received 18 more outperform votes than Rhythm Pharmaceuticals when rated by MarketBeat users. Likewise, 71.90% of users gave Soleno Therapeutics an outperform vote while only 66.59% of users gave Rhythm Pharmaceuticals an outperform vote. CompanyUnderperformOutperformRhythm PharmaceuticalsOutperform Votes28966.59% Underperform Votes14533.41% Soleno TherapeuticsOutperform Votes30771.90% Underperform Votes12028.10% Which has more volatility & risk, RYTM or SLNO? Rhythm Pharmaceuticals has a beta of 2.09, meaning that its stock price is 109% more volatile than the S&P 500. Comparatively, Soleno Therapeutics has a beta of -1.44, meaning that its stock price is 244% less volatile than the S&P 500. Do institutionals and insiders hold more shares of RYTM or SLNO? 97.4% of Soleno Therapeutics shares are held by institutional investors. 5.6% of Rhythm Pharmaceuticals shares are held by insiders. Comparatively, 12.3% of Soleno Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Does the media favor RYTM or SLNO? In the previous week, Rhythm Pharmaceuticals had 7 more articles in the media than Soleno Therapeutics. MarketBeat recorded 8 mentions for Rhythm Pharmaceuticals and 1 mentions for Soleno Therapeutics. Soleno Therapeutics' average media sentiment score of 0.84 beat Rhythm Pharmaceuticals' score of 0.49 indicating that Soleno Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Rhythm Pharmaceuticals 3 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Soleno Therapeutics 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend RYTM or SLNO? Rhythm Pharmaceuticals presently has a consensus target price of $62.30, suggesting a potential upside of 3.94%. Soleno Therapeutics has a consensus target price of $74.83, suggesting a potential upside of 29.51%. Given Soleno Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Soleno Therapeutics is more favorable than Rhythm Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Rhythm Pharmaceuticals 0 Sell rating(s) 1 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.90Soleno Therapeutics 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.14 Is RYTM or SLNO more profitable? Soleno Therapeutics has a net margin of 0.00% compared to Rhythm Pharmaceuticals' net margin of -230.07%. Soleno Therapeutics' return on equity of -61.99% beat Rhythm Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Rhythm Pharmaceuticals-230.07% -367.36% -77.47% Soleno Therapeutics N/A -61.99%-55.21% SummarySoleno Therapeutics beats Rhythm Pharmaceuticals on 13 of the 18 factors compared between the two stocks. Ad Weiss RatingsTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. Get Soleno Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SLNO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SLNO vs. The Competition Export to ExcelMetricSoleno TherapeuticsElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.49B$3.53B$5.37B$8.84BDividend YieldN/A1.70%5.09%4.09%P/E Ratio-17.4018.61105.6017.78Price / SalesN/A68.741,246.32164.54Price / CashN/A47.0340.1236.29Price / Book9.414.047.066.50Net Income-$38.99M$89.83M$119.33M$226.10M7 Day Performance11.54%0.45%2.14%3.96%1 Month Performance7.72%4.90%-3.14%3.77%1 Year Performance106.36%21.07%33.63%29.30% Soleno Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SLNOSoleno Therapeutics4.3263 of 5 stars$57.78+5.8%$74.83+29.5%+106.4%$2.49BN/A-17.4030RYTMRhythm Pharmaceuticals3.1421 of 5 stars$59.27-0.2%$62.30+5.1%+78.8%$3.63B$112.53M-13.69140Analyst ForecastFONRFONAR1.918 of 5 stars$16.45+10.5%N/A-13.7%$104.13M$102.88M11.75480High Trading VolumeEDAPEdap Tms2.7942 of 5 stars$2.49+1.6%$19.00+663.1%-48.5%$90.91M$63.41M-3.83307News CoverageRMTIRockwell Medical4.2695 of 5 stars$2.20-5.6%$7.00+218.2%+22.3%$71.10M$83.61M-46.60300Analyst DowngradeHigh Trading VolumePENPenumbra4.2737 of 5 stars$240.15+0.4%$227.92-5.1%+5.7%$9.22B$1.16B279.244,200Analyst ForecastInsider TradeNews CoverageGKOSGlaukos3.8616 of 5 stars$140.95-0.3%$134.55-4.5%+128.4%$7.77B$360.35M-46.67780News CoveragePositive NewsBLCOBausch + Lomb2.3317 of 5 stars$19.81+2.2%$20.91+5.5%+28.2%$6.98B$4.15B-18.8713,300INSPInspire Medical Systems4.7564 of 5 stars$186.19+0.8%$233.58+25.5%+31.0%$5.58B$624.80M174.011,011Analyst UpgradePositive NewsPRCTPROCEPT BioRobotics1.5908 of 5 stars$94.45+1.9%$89.50-5.2%+169.7%$4.93B$136.19M-48.44626Insider TradeNVSTEnvista3.6756 of 5 stars$21.39+5.0%$20.71-3.2%-10.4%$3.68B$2.57B-2.7512,800 Related Companies and Tools Related Companies Rhythm Pharmaceuticals Alternatives FONAR Alternatives Edap Tms Alternatives Rockwell Medical Alternatives Penumbra Alternatives Glaukos Alternatives Bausch + Lomb Alternatives Inspire Medical Systems Alternatives PROCEPT BioRobotics Alternatives Envista Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SLNO) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Soleno Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Soleno Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SLNO Stock Alerts